Research programme: antifungal drug conjugate - Centrose

Drug Profile

Research programme: antifungal drug conjugate - Centrose

Latest Information Update: 01 Aug 2016

Price : $50

At a glance

  • Originator Wisconsin Alumni Research Foundation
  • Developer Centrose
  • Class Antifungals; Cardiac glycosides; Drug conjugates; Immunoconjugates
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Mycoses

Most Recent Events

  • 01 Aug 2016 No recent reports on development identified for Mycoses in USA (Transdermal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top